TAG:
laboratory outreach program
Middleware Provides Opportunity For Labs to Gain New Functions
By Robert Michel | From the Volume XII No. 17 – December 5, 2005 Issue
“Even as more laboratories begin to use middleware, the number of functions and uses for middleware continues to increase —Gregory R Vail, CEO, Data Innovations, Inc. CEO SUMMARY: Middleware is attracting attention throughout the laboratory ind…
Spectrum Lab Network Is Sold to Equity Investor
By Robert Michel | From the Volume XII No. 16 – November 14, 2005 Issue
CEO SUMMARY: Timing of the sale of Spectrum Laboratory Network to Apax Partners, L.P. was unexpected, but it’s been known for some time that the fast-growing regional laboratory was entertaining purchase offers. Under new ownership and with ready access to ample capital, Spectrum is optimis…
Private Equity Firms: Ready to Buy More Labs?
By Robert Michel | From the Volume XII No. 16 – November 14, 2005 Issue
CEO SUMMARY: Times are good in the laboratory industry. At least that’s the opinion of a growing number of professional investors. They are searching throughout the country for laboratories to acquire. They are motivated by the consistent financial performance of many lab companies, bot…
HCA Buys IRL From MDS, Makes Plans for Future
By Robert Michel | From the Volume XII No. 13 – September 12, 2005 Issue
CEO SUMMARY: When HCA purchased the MDS partner share in Integrated Regional Laboratory of Ft. Lauderdale, Florida, it marked the end of MDS Laboratories’ ten-year “United States Adventure.” It also put HCA in full ownership of an automated core laboratory and a laboratory outreach …
For Quest and LabCorp, The Story is “Molecular”
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
CEO SUMMARY: Wall Street likes the potential of molecular diagnostics to infuse new revenues and operating profits into the laboratory industry. That is one reason Quest Diagnostics Incorporated and Laboratory Corporation of America are assertively seeking exclusive access to new molecula…
Patient ABNs Can Save On Expensive Send-outs
By Robert Michel | From the Volume XII No. 9 – June 20, 2005 Issue
CEO SUMMARY: Throughout the United States, the growing number of high-priced, patent-protected specialty tests is eating into the laboratory budgets of many hospitals. At Hospital Consolidated Laboratories in Southfield, Michigan, this budget-busting threat triggered an innovative respons…
LIS Market Evolving To Serve New Needs
By Robert Michel | From the Volume XII No. 8 – May 30, 2005 Issue
CEO SUMMARY: Ongoing reimbursement declines, coupled with other key factors, are pushing labs to seek new capabilities for their laboratory information systems (LIS). Another influence is the growth of molecular diagnostic programs in hospital labs. Molecular testing places unique demands…
Medicare Managed Care Is Poised to Double in Size
By Robert Michel | From the Volume XII No. 5 – March 28, 2005 Issue
MEDICARE MANAGED CARE PLANS are poised to double in size. This can be both a threat and an opportunity for regional laboratories. The Center for Medicare and Medicaid Services (CMS) recently reported that it had received 141 applications for new local Medicare Advantage plans for 20…
Year-end Financials Released For Quest, LabCorp & LabOne
By Robert Michel | From the Volume XII No. 5 – March 28, 2005 Issue
In RECENT WEEKS, public laboratory companies have released earnings reports for the year-ending December 31, 2004. It was generally a good year for the three largest lab companies that have a major emphasis on providing lab testing services to office-based physicians. In this year’s review, THE DA…
Spectrum Owns MEDex, Comments on Trends
By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue
CEO SUMMARY: Spectrum Laboratory Network recently completed its acquisition of MEDex Laboratories, Inc. of Kingsport, Tennessee. It is becoming a regional laboratory powerhouse, challenging Laboratory Corporation of America in North Carolina and establishing a sales base in Atlanta, long-…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized